Literature DB >> 2804927

Dukes' classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01).

E R Fisher1, R Sass, A Palekar, B Fisher, N Wolmark.   

Abstract

The relative prognostic value of the Dukes, Astler, and Coller and TNM staging systems was evaluated for 745 pathologically evaluable patients with rectal cancer enrolled in protocol R-01 of the National Surgical Adjuvant Breast and Bowel Projects. All three methods were found to be highly interrelated. However, the magnitude and consistency of prognostic discrimination among stages was best exhibited by the Dukes' and TNM systems. Survival was comparable among patients with Astler and Coller A and B1 and TNM T1N0M0 and T2N0M0 lesions. Since neither method improved on the predictability noted in Dukes' A cases it is suggested that the use of confusing subscripts is unnecessary. On the other hand, striking prognostic discrimination was observed when Dukes' C cases were subdivided according to depth of tumor penetration as proposed by Astler and Coller and designated as C1 and C2. Multivariate analyses revealed this feature to be independent of number of nodal metastases (1-4 versus 5+ positive), their site (near or far from the growth), or degree of tumor differentiation. The site of nodal metastases appeared to be related to numbers of nodal metastases rather than site per se. Considerations of the findings indicate that the Dukes' staging method is the simplest and most consistent algorithm related to prognosis. The only modification that would enhance its value in this regard would be the subdivision of C cases according to the criteria of Astler and Coller rather than that proposed by Dukes himself.

Entities:  

Mesh:

Year:  1989        PMID: 2804927     DOI: 10.1002/1097-0142(19891201)64:11<2354::aid-cncr2820641127>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Sporadic loss of leucocyte-function-associated antigen-3 (LFA-3) in colorectal carcinomas.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.

Authors:  Luis C Fernandes; Su B Kim; Sarhan S Saad; Delcio Matos
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

3.  Dukes's classification: a valid prognostic indicator for gastric cancer.

Authors:  Y Adachi; M Mori; Y Maehara; K Sugimachi
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

4.  Prognostic significance of the number of positive lymph nodes in gallbladder cancer.

Authors:  Itaru Endo; Hiroshi Shimada; Mikiko Tanabe; Yoshiro Fujii; Kazuhisa Takeda; Daisuke Morioka; Kuniya Tanaka; Hitoshi Sekido; Shinji Togo
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

5.  Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading.

Authors:  Valeria Barresi; Luca Reggiani Bonetti; Giovanni Branca; Carmela Di Gregorio; Maurizio Ponz de Leon; Giovanni Tuccari
Journal:  Virchows Arch       Date:  2012-10-24       Impact factor: 4.064

6.  Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival.

Authors:  N P Zauber; C Wang; P S Lee; T C Redondo; D T Bishop; A Goel
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

7.  Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.

Authors:  Ji-Cheng Zhang; Zuo-Ren Wang; Yan-Juan Cheng; Ding-Zhong Yang; Jing-Sen Shi; Ai-Lin Liang; Ning-Na Liu; Xiao-Min Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  Colonoscopic indirect lymphangiography in a canine model.

Authors:  D Sudan; S Miller; J Mellinger
Journal:  Surg Endosc       Date:  1993 Mar-Apr       Impact factor: 4.584

9.  Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas.

Authors:  P A Jackson; M A Green; C G Marks; R J King; R Hubbard; M G Cook
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

10.  Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.

Authors:  P A Jackson; M A Green; A Pouli; R Hubbard; C G Marks; M G Cook
Journal:  J Clin Pathol       Date:  1995-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.